Status:
COMPLETED
Multicenter Evaluation of Right Colon Polyp Miss Rates Using Water Exchange Versus CO2 Insufflation
Lead Sponsor:
Evergreen General Hospital, Taiwan
Collaborating Sponsors:
Taipei Medical University Hospital
Dalin Tzu Chi General Hospital
Conditions:
Right Colon Adenoma Miss Rate
Right Colon Hyperplastic Polyp Miss Rate
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
A prospective multicenter randomized controlled trial (RCT) comparing water exchange (WE) colonoscopy and carbon dioxide (CO2) insufflation in terms of right colon combined adenoma miss rate (AMR) and...
Detailed Description
This will be a prospective RCT comparing CO2 insufflation and WE in terms of right colon combined AMR and HPMR by tandem inspection. It will be a multicenter study conducted in three community hospita...
Eligibility Criteria
Inclusion
- Consecutive patients aged 45 years or older undergoing colonoscopy for screening, surveillance, and positive fecal immunochemical test will be considered for enrollment.
Exclusion
- Familial adenomatous polyposis and hereditary non-polyposis colorectal cancer (CRC) syndrome, personal history of CRC or inflammatory bowel disease, previous colonic resection, obstructive lesions of the colon, gastrointestinal bleeding, allergy to fentanyl, midazolam or propofol, American Society of Anesthesiology classification of physical status grade 3 or higher, mental retardation, pregnancy, and refusal to provide a written informed consent.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
386 Patients enrolled
Trial Details
Trial ID
NCT04124393
Start Date
December 1 2019
End Date
December 31 2022
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evergreen General Hospital
Taoyuan District, Taiwan